for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

UBI Pharma Inc

6562.TWO

Latest Trade

82.80TWD

Change

-3.40(-3.94%)

Volume

1,890,577

Today's Range

78.50

 - 

89.30

52 Week Range

37.50

 - 

300.00

As of on the Gre Tai Security Market ∙ Minimum 15 minute delay

Latest Developments

UBI Pharma gets patent in EU

May 17(Reuters) - UBI Pharma Inc <6562.TWO>:Says it gets patent named RECOMBINANT PROTEIN from European Patent Office.

UBI Pharma passes U.S FDA review of clinical trial in human for anticancer drug

UBI Pharma <6562.TWO>:Says its new anticancer drug UB-941 passed review of clinical trial in human of U.S FDA.

UBI Pharma to pay 2015 dividend on Sep. 30

UBI Pharma <6562.TWO>: Says it will pay cash dividend of T$2,387,049 in total for 2015 . Says ex-dividend date Aug. 25 . Last date before book closure Aug. 28 with book closure period from Aug. 29 to Sep. 2 . Record date Sep. 2 .Payment date Sep. 30.

UBI Pharma announces 2015 dividend payment

UBI Pharma Inc:To use undistributed profit to pay cash dividends of T$0.01688100 per share to shareholders for 2015.To pay cash dividend of T$2,387,049 in total.

UBI Pharma to change head of finance

UBI Pharma Inc:To change head of finance to Xu Menghan from Hong Jiawei, effective April 11.

UBI Pharma announces initial public offering

UBI Pharma Inc:Announces initial public offering of 141,399,055 common shares with par value of T$10 per share.Shares to be traded on the emerging market under the symbol of "6562" from Jan. 22.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up